Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FREEDOM: Dexamethasone Discontinuation in Relapsed/Refractory Multiple Myeloma
NCT06561854Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2024
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in multiple myeloma (MM), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2024; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT06561854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06561854.